Cargando…

Multimorbidity, polypharmacy, and mortality in older patients with pacemakers

BACKGROUND: The prevalence of multimorbidity and polypharmacy and its association with all‐cause mortality in older patients with pacemakers are largely unknown. We aimed to clarify the prevalence of multimorbidity and polypharmacy, and its association with all‐cause mortality in patients ≥75 years...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goto, Toshihiko, Mori, Kento, Nakayama, Takafumi, Yamamoto, Junki, Shintani, Yasuhiro, Wakami, Kazuaki, Fukuta, Hidekatsu, Seo, Yoshihiro, Ohte, Nobuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851581/ https://www.ncbi.nlm.nih.gov/pubmed/35222761 http://dx.doi.org/10.1002/joa3.12660

Ejemplares similares

Transmission Rate of Remote Monitoring and Mortality in Patients With Pacemaker
por: Goto, Toshihiko, et al.
Publicado: (2020)

Verification of Echocardiographic Assessment of Left Ventricular Diastolic Dysfunction in Patients With Preserved Left Ventricular Ejection Fraction Using the American Society of Echocardiography and European Association of Cardiovascular Imaging 2016 Recommendations
por: Yamamoto, Junki, et al.
Publicado: (2019)

Reclassification of Heart Failure with Preserved Ejection Fraction Following Cardiac Sympathetic Nervous System Activation: A New Cutoff Value of 58%
por: Goto, Toshihiko, et al.
Publicado: (2022)

Non-Invasive Estimation of Left Ventricular Filling Pressure Based on Left Atrial Area Strain Measured With Transthoracic 3-Dimensional Speckle Tracking Echocardiography in Patients With Coronary Artery Disease
por: Banno, Tomoyuki, et al.
Publicado: (2021)

Prognostic Value of Left Ventricular Diastolic Dysfunction in Patients Undergoing Cardiac Catheterization for Coronary Artery Disease
por: Fukuta, Hidekatsu, et al.
Publicado: (2012)

Patients with left ventricular ejection fraction greater than 58 % have fewer incidences of future acute decompensated heart failure admission and all-cause mortality
por: Goto, Toshihiko, et al.
Publicado: (2015)

Ventricular Sigmoid Septum as a Risk Factor for Anthracycline-Induced Cancer Therapeutics-Related Cardiac Dysfunction in Patients With Malignant Lymphoma
por: Nakayama, Takafumi, et al.
Publicado: (2022)

Clinical features of anthracycline‐induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single‐center, retrospective observational study
por: Nakayama, Takafumi, et al.
Publicado: (2020)

Impact of differences in embryonic origin on the electrical features of the giant right atrium in an elderly patient
por: Goto, Toshihiko, et al.
Publicado: (2021)

Unusual interventional treatment of spontaneous coronary artery dissection without stent implantation: a case series
por: Fujita, Hiroshi, et al.
Publicado: (2021)

Left ventricular contractile performance and heart failure in patients with left ventricular ejection fraction more than 40%
por: Kitada, Shuichi, et al.
Publicado: (2020)

Infected Aortic Aneurysm Mimicking Anti-proteinase 3-Antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Hachiya, Kenta, et al.
Publicado: (2016)

A case of an elderly female who developed subacute pleuropericarditis following BNT162b2 mRNA COVID-19 vaccination
por: Mizoguchi, Tatsuya, et al.
Publicado: (2022)

Multimorbidity and polypharmacy: a risk factor for older patients
por: Cucinotta, Domenico
Publicado: (2022)

Intraprocedural Thrombotic Events during Percutaneous Coronary Intervention Due to Acquired Antithrombin Deficiency-related Heparin Resistance Successfully Treated with Antithrombin Gamma Supplementation
por: Yokoi, Masashi, et al.
Publicado: (2022)

Association of epicardial fat with cardiac structure and function and cardiovascular outcomes: A protocol for systematic review and meta-analysis
por: Fukuta, Hidekatsu, et al.
Publicado: (2023)

Effects of beta-blocker withdrawal in patients with heart failure with preserved ejection fraction: A protocol for systematic review and meta-analysis
por: Fukuta, Hidekatsu, et al.
Publicado: (2023)

Polypharmacy in multimorbid older adults: protocol for a systematic review
por: Sirois, Caroline, et al.
Publicado: (2017)

Multimorbidity or polypharmacy: two sides of the same coin?
por: Sinnott, Carol, et al.
Publicado: (2015)

Italian guidelines on management of persons with multimorbidity and polypharmacy
por: Onder, Graziano, et al.
Publicado: (2022)

Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice
por: von Buedingen, Fiona, et al.
Publicado: (2018)

Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
por: Villén, Noemí, et al.
Publicado: (2022)

Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
por: Zhao, Yong, et al.
Publicado: (2023)

Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese population
por: Aoki, Takuya, et al.
Publicado: (2018)

Dilated Cardiomyopathy with Eosinophilic Granulomatosis with Polyangiitis in Which Active Myocardial Inflammation Was Only Detected by Endomyocardial Biopsy
por: Nakayama, Takafumi, et al.
Publicado: (2018)

Comparison of Hemorrhagic Risk between Prasugrel and Clopidogrel: a Retrospective Study using Adverse Drug Event Reporting Databases
por: Hagiwara, Hiromi, et al.
Publicado: (2020)

L/T-type calcium channel blocker reduces non-Gaussianity of heart rate variability in chronic kidney disease patients under preceding treatment with ARB
por: Fukuda, Michio, et al.
Publicado: (2016)

Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark
por: Schiøtz, Michaela L., et al.
Publicado: (2018)

Longitudinal data of multimorbidity and polypharmacy in older adults in Taiwan from 2000 to 2013
por: Lai, Shih-Wei, et al.
Publicado: (2020)

Malondialdehyde-Modified Low-Density Lipoprotein as a Predictor of Major Adverse Limb Events after Endovascular Therapy in Patients with Lower Extremity Arterial Disease
por: Yokoi, Masashi, et al.
Publicado: (2023)

Obesity and Polypharmacy among African American Older Adults: Gender as the Moderator and Multimorbidity as the Mediator
por: Assari, Shervin, et al.
Publicado: (2019)

Delayed right ventricular perforation complicated by intracardiac thrombosis after implantable cardioverter‐defibrillator implantation
por: Ito, Tsuyoshi, et al.
Publicado: (2017)

Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM Trial
por: Sibille, François-Xavier, et al.
Publicado: (2023)

The evolution of an evidence based intervention designed to improve prescribing and reduce polypharmacy in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE)
por: McCarthy, Caroline, et al.
Publicado: (2020)

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015
por: van den Akker, Marjan, et al.
Publicado: (2019)

Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management
por: Patel, Preya Janubhai, et al.
Publicado: (2017)

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2020)

Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland
por: Zechmann, Stefan, et al.
Publicado: (2019)

Life-course socioeconomic conditions, multimorbidity and polypharmacy in older adults: A retrospective cohort study
por: Jungo, Katharina Tabea, et al.
Publicado: (2022)

Repeated recapture of a leadless pacemaker leads to tether fracture
por: Goto, Toshihiko
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s6adq468ndonhlp18aotpmmrov